Both miRNAs were subsequently detected in the CSF of the patient from whom the iPSC line had been derived, as well as in additional LRRK2 G2019S carriers and a sPD case, highlighting their potential relevance beyond the in vitro model. Here, LRRK2 is linked to Platelet storage pool disease.